Skip to main content

Transgenesis in parasitic helminths: a brief history and prospects for the future

Abstract

Helminth infections impact the health of hundreds of millions of persons globally and also cause important economic losses in livestock farming. Methodological limitations as well as the low attention given to the study of helminths have impacted biological research and, thus, the procurement of accurate diagnosis and effective treatments. Understanding the biology of helminths using genomic and proteomic approaches could contribute to advances in understanding host–helminth interactions and lead to new vaccines, drugs and diagnostics. Despite the significant advances in genomics in the last decade, the lack of methodological adaptation of current transgenesis techniques has hampered the progression of post-genomic research in helminthology. However, the application of new techniques, such as CRISPR, to the study of trematodes and nematodes has opened new avenues for genome editing-powered functional genomics for these pathogens. This review summarises the historical advances in functional genomics in parasitic helminths and highlights pending limitations that will need to be overcome to deploy transgenesis tools.

Graphical Abstract

Background

Approximately one sixth of the human population is infected with parasitic helminths [1, 2], mainly in countries in tropical and subtropical regions, causing growth delay and cognitive development disruption in children as well as significant morbidities and chronic disabilities in adults [3, 4]. Globally, helminth infections have been estimated to have resulted in approximately 14 million disability-adjusted life years (DALYs) lost yearly during the last decade [1]. In addition, the estimated annual cost in Europe associated with helminth infections in livestock (gastrointestinal nematodes, common liver flukes and bovine lungworm) is close to 2 billion euros [5]. Despite the medical and economical importance of helminthiases, the study of these diseases receives less than 1% of the global research budget, and most are still considered as neglected tropical diseases [5].

The most common human diseases are caused by soil-transmitted helminths (STHs) causing ascariasis, trichuriasis and hookworm infection (necatoriasis, ancylostomiasis), followed by schistosomiasis and lymphatic filariasis [1]. Some anthelmintic drugs have been developed and used for the treatment of helminthiases, but with some limitations. For example, anthelmintic drugs do not protect against reinfection, and treatment failure because of repeated use of these drugs has drawn attention to the development of drug resistance [6]. In addition, despite the promise of attenuated larvae, the use of which has shown promising results in vaccine studies, recombinant and epitope-based vaccine candidates show variable efficacy [2, 7, 8]. For example, a phase 1 clinical trial using ultraviolet-attenuated Necator americanus larvae elicited an antigen-specific humoral and cellular immune response that resulted in reduced larval output in vaccinated participants [8]. In contrast, recombinant protein-based vaccines have confirmed safety in humans, such as the glutathione-S-transferase of Schistosoma haematobium, but which was found to be ineffective in protecting from reinfection in a phase 3 study [9]. Despite all attempts, most vaccines against helminth infections remain trapped in early-stage development or are undergoing pre-clinical evaluation, and no human anti-helminth vaccine has yet been approved for widespread use [7, 10].

Identifying suitable protective antigens is one of the major challenges in vaccine design. This step relies on the availability of well-curated genomic, transcriptomic and proteomic databases, as well as on a detailed knowledge of helminth biology. Notwithstanding, the marked complexity as well as the limitations in availability and access to samples still represent a great handicap for basic research on helminth infections [11].

Progress in helminth biology research has gone hand in hand with the advances in techniques for genome sequencing and proteome characterisation. Helminth parasites have a large complex genome, ranging from approximately 42 to > 1000 Mb with up to 18,000 protein-coding genes [12]. The whole-genome shotgun (WGS) method was used to produce the first parasite genome, that of the filarial nematode Brugia malayi, in 2007 [13]. The rapid development of new sequencing platforms, such as Roche 454 sequencing system (Roche Diagnostics) and Illumina sequencing platforms (Illumina, Inc.) offered 1000-fold increase in throughput over the Sanger sequencing technology and supported the progressive publication of more helminth genomes [11]. Indeed, projects such as the 50 Helminth Genome Initiative have contributed to the list of 157 nematode and 45 platyhelminth genomes currently published at the WormBase ParaSite database [14]. As data on helminth genomes grew in magnitude, new transcriptomic and proteomic data were also released. In 2010, the complete transcriptome of the human liver fluke Clonorchis sinensis was reported which, soon after, gave place to proteomic studies that revealed the metabolic changes between aerobic and anaerobic pathways that evolved with the diverse niches colonised through the life-cycle [15]. The availability of these “omics” data has underpinned the development of transgenesis and genome-editing research, rendering key information on the molecular biology of helminths. From the early studies using biolistics and the microinjection of plasmids [16,17,18] to the recently deployed CRISPR/Cas9 (Clustered regularly interspaced palindromic repeats/CRISPR-associated) systems [19, 20] in nematodes and trematodes, these advances have contributed to a diverse array of pathways and processes, including the characterisation of immune responses and immunomodulatory molecules, as well as of the key proteins involved in haemoglobin digestion and tegument integrity in platyhelminths [21,22,23,24]. Despite the many steps forward, however, most of the helminth genomic data still consist of partial draft assemblies, and numerous “hypothetical” genes remain uncharacterised [25]. A profound comprehension of the applications and limitations of transgenesis available techniques will allow us to select the correct techniques as well as to explore the alternatives and improvements to widen our research possibilities and, thus, our knowledge on helminth biology. This review explores current knowledge, prospects and challenges for research on helminth biology through transgenesis techniques.

First steps in helminth transgenesis

Countless advances in genomic research have been made since reports of the first targeted genomic changes produced in yeast and mice in the 1970s and 1980s, respectively. These advances have focussed on the reduction of the off-target effects, the enhancement of the efficiency and its application to different species [26].

Although transgenic lines have been established for numerous species, this feat has been achieved only in a few helminths. In addition to the associated obstacles of genome editing, research on helminths presents considerable obstacles in the context of genetic manipulation, due both to their biological complexity and to the requirements of parasitism [23]. For example, the life-cycle of most helminths consists of several developmental stages which are associated with morphological and biochemical changes that confer the ability to survive in different host/external environments. Furthermore, nematodes and platyhelminths frequently need intermediate hosts to complete their life-cycle, which makes their maintenance in the laboratory particularly challenging [27]. This complexity has traditionally hampered the establishment of stable transgenic lines in parasitic helminths. Not surprisingly, advances in the transgenesis of helminths occurred on the basis of Caenorhabditis elegans transgenesis, beginning in 1982 with the first successful transformation of this free-living nematode [28].

As important as selecting the appropriate genomic construct, providing the specific and highly effective technique for transfection is essential for programmed editing of the helminth genome. As new techniques have emerged, research possibilities have been expanded, but there are still imposing impediments to overcome in the research of different helminth species, as discussed in the following sections.

Plasmid-based vectors

Early DNA constructs consisted of plasmid-based vectors that resulted in the assembly of transgene sequences into extrachromosomally inherited, multi-copy arrays, as shown in 1991 in the free-living model nematode, C. elegans [30]. Plasmids incorporate the gene of interest in combination with a selection marker, a transcriptional reporter and the corresponding cellular sequences for transcription and translation. In addition, the addition of shared homology sequences has allowed for the integration of these arrays into the chromosome [29, 31]. A wide range of delivery techniques have been applied over the years for plasmid-based transgenesis in the search for higher efficiency rates and stable lines. The first transient transfections of a fluorescent reporter transgene were accomplished in 1999 for the embryos of the parasitic nematode Ascaris suum and the adults of the trematode Schistosoma mansoni [16]. It was not until 2008 that the first successful transient transfection of primary cells of the cestode Echinococcus multilocularis was attained based on soaking [32]; this also opened the possibility to study the facultative intracellular bacterium Listeria monocytogenes as a method to introduce foreign DNA into Echinococcus cells. Spiliotis and co-authors reported the expression of the reporter gene by these bacteria after cytosolic lysis but without integration in the chromosomes of E. multilocularis (Fig. 1) [32].

Fig. 1
figure 1

Historical advances in the transgenesis of parasitic helminths. The image shows the first successful transient/stable transgenesis of different species of nematodes (a), trematodes (b) and cestodes (c) using biolistics, microinjection, soaking, electroporation and lentiviral or bacterial vectors. Stable lines are highlighted in green. For full name of species, as well as reference number of citations, see Table 1

sBiolistics-based transient transgenesis of S. mansoni revealed the tissue expression of the cathepsin F and B2 in the gut and tegument of this trematode, respectively [33]. This method was also applied to B. malayi and compared to microinjection, showing that the fluorescence activity of the microinjected parasites was higher than that seen in the biolistically transfected adults (Fig. 1; Table 1) [17]. Transfection mediated by microinjection of the cestode Taenia crassiceps was successful in expressing the GFP reporter under the control of a cytomegalovirus (CMV) promoter in 2015 (Fig. 1; Table 1) [34]. Considering these results and the high level of mortality among bombarded parasitic helminths, microinjection and other techniques generally have replaced biolistics in helminth plasmid-based transgenesis [29].

Table 1 First and key examples of transgenesis in nematodes, trematodes and cestodes of human and veterinary impact, the gene targeted and the methodology used

Heritable and stable transfection is readily obtained in C. elegans through the gonadal microinjection of plasmid-based vectors [35]. Techniques developed for C. elegans were conveniently adapted to parasites deploying at least one generation of free-living development, with adult males and females residing in soil contaminated by host-infected faeces [35]. In 2002, Lok and co-workers carried out the transfection of Strongyloides stercoralis by microinjection, but the expression of green fluorescent protein (GFP) was only detected on the maternal gonads and none of the transformed embryos hatched (Fig. 1; Table 1) [18]. Four years later, heritable transgenesis of the parasitic nematode Parastrongyloides trichosuri was achieved using microinjection (Fig. 1; Table 1) [36].

Early transgenesis research on S. stercoralis attempted the transgenesis with the collection of modular C. elegans transformation vectors which were designed to incorporate any promoter and coding sequence upstream of a multipurpose terminator called unc-54 3′untranslated region (UTR) [37]. However, it was not until a parasite-specific 3′UTR was incorporated that constructs were expressed in a sustained and tissue-specific pattern in developing larval and adult Strongyloides [37]. GFP from a plasmid-encoded transgene was detected by PCR in S. stercoralis transiently after microinjection, for at least five passages; however, the expression of this transgene could not be detected in transgenic worms from subsequent passages [37]. These investigators hypothesised that S. stercoralis gathered plasmid-encoded transgenes into tandem, multi-copy, episomal arrays that were inherited, but silenced after the first host passages due to their highly repetitive nature, their episomal location or both [38]. Similarly, initial plasmid-based transgenesis in Strongyloides ratti exhibited only transient expression of a fluorescent reporter (Fig. 1; Table 1) [39]. By integrating the transgene into the chromosome through the usage of the piggyBac (PB) transposon system, stable and heritable expression was achieved in 2012 for S. ratti, and 1 year later for S. stercoralis (Table 1) [31, 40]. The activity of PB in S. mansoni and integration of the transposon into schistosome chromosomes was reported several years earlier [41]. This system efficiently transposes between chromosomes and vectors via a “cut and paste” reversible activity of the PB transposase. The ability to integrate into the helminth genome made transposon and retrotransposons likely candidates as vectors to develop stable transfections [42].

The establishment of stable transgenic lines was possible initially in the well-adapted host parasite pairing of S. ratti in the rat host, which, added to the 50% efficiency of infection, has promoted the successful host passage of small numbers of transgenic iL3 in the first three generations of line establishment in 2012 (Table 1) [31]. Accordingly, the expression of a fluorescent reporter gene under the control of the actin promoter of S. stercoralis was uniformly detected for at least in 10 generations of passage (Table 1) [31]. The same protocol allowed for the transgenic expression of a specific T-cell epitope, which was able to constitute both Th2 and Treg populations from the initial helminth-activated CD4 + T cells, in S. ratti, unravelling novel features of the immune response to this nematode (Table 1) [21].

Subsequent relevant improvements were related to the potentially confounding effects of transgene overexpression from high-copy arrays, initially observed in C. elegans, which prompted the search for methods for low- or single-copy transgene integration into the chromosome [43]. A system for single-copy insertion of transgenesis mediated by the Mos1 transposon from Drosophila mauritiana was devised for C. elegans in 2012 [43]. When worms are subjected to heat shock, the transposase is expressed from the “transposase array” and catalyses the transposition of Mos1 from the “transposon array” into chromosome loci. Mos1 insertions represent molecular tags that are readily identified using inverse PCR [43].

Retroviral vectors alone or in combination with soaking or electroporation have also been used for the delivery of reporter transgenes in the transgenesis of helminths [44, 45]. The approach leverages, firstly, the essential nature of the life-cycle of this family of RNA viruses, specifically the proviral stage of the life-cycle that integrates as DNA into the genome of the host cell and, second, the pseudotyping of the virion with the vesicular stomatitis virus glycoprotein (VSVG), which expands the target host range. For example, Kines et al. accomplished transient luciferase expression in S. mansoni eggs using retroviral particles for plasmid delivery in 2006 (Table 1) [44], and soon thereafter in soaked schistosomula in Moloney murine leukaemia retrovirus (MLV) pseudotyped with VSVG, with the aim of delivering reporter transgenes into schistosome chromosomes [46]. Southern hybridisation analysis indicated the presence of proviral MLV retrovirus in the transduced schistosomes; subsequently, fragments of the MLV transgene and flanking schistosome sequences were recovered using an anchored PCR-based approach, thereby demonstrating definitively that somatic transgenesis of schistosome chromosomes had taken place and revealing widespread retrovirus integration of the provirus of this mammalian retrovirus into the schistosome chromosomes. In addition, these investigators also reported that more efficient transduction of schistosome eggs was feasible using square wave electroporation in tandem with soaking of schistosome eggs with the VSVG pseudotyped MLV virions (Fig. 1; Table 1) [45]. Notably, these researchers also reported germline transgenesis of S. mansoni following retroviral transduction of newly laid eggs, and the expression of a transgene encoding resistance to aminoglycoside antibiotics in the F1 progeny [47, 48].

As with biolistics, electroporation can lead to significant mortality, and this technique also requires the transfer of worms, prior to culturing, into cuvettes with nucleic acids in minimal salt solution to avoid arcing, which increases the possibility of contamination [49]. For these reasons, in 2013, Liang et al. proposed the use of chemical transfectants (e.g. polyethyleneimine) or co-precipitates in combination with the transgene DNA since these can improve the DNA uptake by promoting the binding to the cell surface and the subsequent endocytosis, as shown in schistosomes [49]. Additional successful transgenesis using this technique has been accomplished in B. malayi L3 [50]. These investigators suggested that exposing the infective stage filariae to a solution containing calcium phosphate and the transfecting plasmid DNA during a larval moulting cycle would increase the uptake possibly due to a higher catching ability of the nascent cuticle [50]. Indeed, various parasitic nematode species produce larvae that are able to undergo one or more complete moults in vitro or in accessible locations in mammalian or vector hosts [50].

RNA interference

Plasmid-based vector techniques have paved the way for parasitic helminth transgenesis. Many limitations had been overcome through the single-copy insertion of the transgene into the chromosome, but random integration still represented a disadvantage for functional genomics since it could interfere with the expression of crucial genes for worm development and survival [31]. Furthermore, the production of stable intrachromosomal transgenic lines was also associated with high costs and intense workload. Consequently, much of the research effort to date has instead focussed on the downregulation of post-transcriptional gene expression through interfering RNAs using the RNA interference (RNAi) technique. RNAi is a very powerful tool that emerged from research on so-called non-coding RNAs (ncRNAs). These molecules vary not only in length (small and long ncRNAs with > 200 nt) but also in their biogenesis and roles in the cell [51]. A diverse variety of ncRNAs are known, but it is principally microRNAs (miRNA) that have attracted much attention due to their ability to inhibit mRNA translation by increasing their degradation or decreasing their stability. Similar to miRNA bioprocessing, researchers have managed to introduce exogenous long double-stranded RNAs (dsRNAs) that are cleaved in the cytoplasm by Dicer, rendering functional small interfering RNAs (siRNAs) which, as miRNAs, are able to promote the degradation of the targeted RNAs [51]. As demonstrated in C. elegans, RNA uptake and spreading starts in the intestine where the transmembrane transporter SID-1 is mainly expressed [52]. Likewise, a schistosome SID-1 homologue has been identified, suggesting that siRNAs initially accumulate faster in the gut and, considering the syncytial tissue of schistosomes, traverse large distances internally without the need to cross additional plasma membranes [53]. Additionally, siRNAs can be more efficient inhibitors when multiple oligonucleotides with distinct sequences are used against the same target [54]. Although it is possible to obtain siRNAs directly, dsRNA is more stable to RNase digestion and is more economical to produce than siRNAs [55]. For these reasons and the ease of RNA synthesis in comparison to protein synthesis, dsRNAs, designed for siRNA pathways, are still one of the most useful tools for the repression of gene expression in biology research [51].

Despite gene silencing by RNAi being successfully applied to a wide variety of organisms, including protozoa, amphibians, insects and a number of parasitic helminths infecting plants, animals and humans, RNAi has generated inconsistent and variable results between helminth species and between different genes within a species [56]. In comparison to nematodes (e.g. Nippostrongylus brasiliensis in 2002) and trematodes (e.g. S. mansoni in 2005), cestode research lagged due to the absence of robust reverse genetic methods until 2008 when E. multilocularis germinal cells were successfully transfected (Fig. 1; Table 1) [23, 32, 57].

Several single or combined delivery techniques have been tested over the last decades in the search for approaches to improve dsRNA uptake by helminths. In the free-living nematode C. elegans, RNAi can be effectively induced by simply soaking worms in dsRNA solution since this nematode possesses membrane channels (Systemic RNA Interference Defective [SID]) involved in the intestinal uptake of exogenous dsRNA into the cells (SID-1) and in the systemic spread of this dsRNA (SID-2) [53, 55]. In parasitic nematodes, soaking-based RNAi silencing transgenesis was first applied to N. brasiliensis, where soaking with acetylcholinesterase (AChE) B-specific dsRNA for 24 h gave potent suppression of all three secreted acetylcholinesterases (AChE A, B and C), but did not affect the motility (Fig. 1; Table 1) [57]. As a possible explanation, the authors hypothesised that the selected 5’ region of the ache B gene overlaps with the A and C isoforms but diverges from the neuromuscular AChEs. However, the conditions required for RNAi adversely affected the ability of N. brasiliensis to re-establish infections for further characterisation [57]. Soon after, Aboobaker and co-workers silenced the β-tubulin and RNA polymerase II large subunit genes of B. malayi, resulting in reduction of transcript levels and death of adult female nematodes in culture (Fig. 1; Table 1) [58]. Other successful silencing manipulations based on soaking helped researchers examine the role of gene products from parasitic nematodes such as Haemonchus contortus (H11 aminopeptidase) and A. suum (enolase), generating a significant reduction in worm burden and in worm length, respectively (Table 1) [59, 60].

In like fashion, trematodes were also analysed through silencing techniques based on soaking. For example, in 2005, Cheng et al. accomplished a 75% reduction in the transcript level of the gynecophoral canal protein of Schistosoma japonicum that, as established in previous studies, is expressed in the adult male worm and plays a critical role in the development of the male worm and in pairing with the female (Fig. 1; Table 1) [61]. Consistently, immunofluorescence results confirmed the inhibition of the expression of this protein in a dose-dependent manner [60]. Soaking-based silencing approaches also revealed the requirement for cathepsins (B and L) from the infective stage of Fasciola hepatica in the penetration of the rat intestinal wall since edited worms displayed a variety of movements, erratic locomotion and paralysis (Fig. 1; Table 1) [62]. The same approach revealed the role of tetraspanins in the maintenance of tegument integrity in the trematode S. mansoni, considering the thinner and more vacuolated tegument of modified worms compared to controls and, thus, provided a potential mechanism for the efficacy of tetraspanin-based vaccines against schistosomes (Table 1) [24]. For F. hepatica, Dell’Oca and co-workers also showed that a combined electro-soaking method gives persistent gene silencing for up to 3 weeks, opening the possibility to perform functional validations of therapeutic targets in vivo [63].

Recent large-scale RNAi screening analysis in S. mansoni has uncovered more than 250 potential therapeutic targets affecting neuromuscular function, tissue integrity, stem cell maintenance and parasite survival [64]. Furthermore, this genome-wide screen has provided information about the biochemical interferences produced by existing pharmacological agents. For example, the proteasome inhibitor ixazomib, as well as the inhibitor bortezomib, altered both the movement and attachment of schistosomes [65]. Additionally, the study of different inhibitors of the p97 protein, a component of the ubiquitin–proteasome system (UPS), as well as the long-term treatment with p97-specific RNAi, led to extensive tissue degeneration and death in vitro and, thus, exhibited the crucial role of the proteasome in S. mansoni survival [64].

Early RNAi-based experiments in cestodes studied the relative efficiencies of soaking and electroporation. In 2010, the successful knockdown of the actin transcript revealed the role of this protein in tegument integrity and the contractile ability of the ruminant cestode Moniezia expansa since worms exposed to act-1 dsRNA exhibited significant impairment of tegument formation and contractile ability (Fig. 1; Table 1) [66]. To avoid extended culture outside of the host, a combined soaking and electroporation method was used, generating a reduction of 71% in actin transcript levels [66]. Electroporation alone and in combination with soaking was applied in studies of the trematode Opisthorchis viverrini, generating decreased expression levels and decreased activity of cathepsin B (90%) and tetraspanin-1 (72%) [67, 68]. The resulting phenotypes, including the display of a distinctly vacuolated and thinner tegument in worms treated with dsRNA targeting tetraspanin-1, exposed a crucial role of the targeted gene in tegument integrity in O. viverrini. (Fig. 1; Table 1) [67]. Notwithstanding, silencing studies in the cestode E. multilocularis showed that 10 min of electroporation was sufficient for the introduction of siRNA (72% efficiency), while soaking alone reached lower silencing levels (22%) (Fig. 1; Table 1) [69]. In contrast, delivery of target-specific dsRNA by soaking to the cestode Hymenolepsis microstoma, resulted in 80% suppression of the Hox transcription factor (Fig. 1; Table 1) [70]. However, the limited growth achieved prevented the characterisation of potential loss of function phenotypes in this study [70].

The high efficiency obtained with electroporation led to a progressive increase in the use of this method, while other delivery techniques were also tested. The successful transient transfection of S. mansoni using a luciferase-encoding RNA via electroporation in 2004 opened the possibility to apply the RNAi technology more widely [71]. Consequently, the same investigators proceeded to test electroporation-based silencing of the cathepsin B gene. Resulting phenotypes, including growth retardation without loss of the gut heme pigmentation, highlighted the crucial role for this protein in the normal growth of this parasite [23]. Indeed, suppression of target mRNA was tenfold greater here than in previous studies utilising the soaking method [23].

Nonetheless, the application of electroporation has been far less successful in nematodes than in parasitic platyhelminths. The main limitation appears to be the low permeability of the non-cellular nematode cuticle, which differs from the syncytial tegument of trematodes and cestodes [72]. In larval and adult N. brasiliensis, only partial and inconsistent knockdown of transgene expression was achieved. Consequently, this method does not provide a viable means of delivery in nematodes such as N. brasiliensis [72].

Alternatively, feeding of bacteria engineered to express dsRNA has been used very effectively for dsRNA delivery in C. elegans, although it was not effective when Escherichia coli expressing dsRNA was tested for N. brasiliensis, H. contortus and Heligmosomoides polygyrus [72]. It is also necessary to consider that infective larvae are developmentally arrested in strongylid nematodes and do not feed, presenting a problem in terms of dsRNA delivery [72]. In this regard, chemical exposure and maintenance at elevated temperature can enhance feeding [73,74,75]. Resorcinol and octopamine stimulate uptake of dsRNA by plant-parasitic nematodes [74, 75], and exposure of N. brasiliensis L3 to 37 ºC for 4 h proved sufficient to stimulate feeding, although inconsistent knockdown results were obtained [73].

Subsequent to the first successful application of RNAi by microinjection being achieved in 2010 in the (free-living) planaria of the genus Dugesia [76], this delivery technique has been widely used, generally for silencing experiments in platyhelminths. The possibility of performing gene functional analysis by RNAi led to the isolation of elements involved in the control of patterning and axial polarity during planarian regeneration and homeostasis [76]. Microinjection-based silencing has been applied to nematodes, such as Pristionchus pacificus, and to the blood fluke S. japonicum, generating a non-rolling F1 progeny and showing the crucial role of cathepsin B1 in the digestion of haemoglobin, respectively (Table 1) [77, 78]. Furthermore, by microinjecting the dsRNA into the tail vein of infected mice, a highly effective and specific method for suppressing the gene encoding cathepsin B1 expression in vivo was established for S. japonicum [77]. The reduced expression of cathepsin B1 resulted in less heme pigmentation in the intestinal tissue, reflecting reduced haemoglobin digestion, which explains the growth retardation of schistosomula in mice [77]. After the successful transient plasmid-based transfection of T. crassiceps in 2015, Moguel et al. continue to explore delivery strategies for the introduction of dsRNA and the generation of stable transfection in T. crassiceps, including the PB transposon [49].

Recently, helminth transgenesis has deployed pseudotyped retroviral vectors to explore new methods to obtain higher transformation efficiency [29, 79]. Specifically, a lentivirus-based transduction system containing miRNA-adapted short hairpin RNAs (shRNAmirs) was employed in 2014 for the knockdown of the omega-1 gene in S. mansoni eggs, which significantly decreased the volume of circumoval granuloman mice infused intravenously with these eggs (Fig. 1; Table 1) [80]. Short hairpin RNAs (shRNAs) are artificial RNA molecules synthesised within the cell by DNA vector-mediated integration. They consist of two complementary 19- to 22-bp RNA sequences linked by a short loop of 4–11 nt that is similar to the hairpin found in cellular miRNA [81]. Ultimately, the success of transformation relies on the susceptibility of the schistosome’s tegument to lentivirus transduction which, as mentioned for electroporation, presents similar difficulties for its application in nematodes. Nevertheless, the epithelial layer of the nematode gut may allow the entry of pseudotyped viruses [29, 79]. Indeed, the recent transfer of lentiviral vectors encoding shRNAmers into the nematode N. brasiliensis has been successfully obtained through the feeding of third-stage larvae (L3) with lentiviral particles that entered via the intestine and transcribed siRNAmers in eggs and infective larvae (Fig. 1; Table 1). Nonetheless, no obvious phenotypic effect after silencing any of the targets (β-tubulin isotype-1 and secreted acetylcholinesterase B) were observed in L3 in vitro, possibly due to the modest knockdown of target mRNA achieved and the lack of shRNAmer expression in adult worms (Table 1) [82]. The authors hypothesised that the lack of transcription could be due to chromatin-mediated transcriptional silencing of the viral integration site during parasite development. Further optimisation of the expression cassette is needed to overcome the problem of transcriptional silencing during development [82].

Advanced techniques: CRISPR/Cas9

As noted, RNAi-based gene silencing has helped reveal some gene functions crucial for studying the biology of helminths of clinical and veterinary importance. However, RNAi often produced undetectable or subtle phenotypic changes and was either transient or the inheritance of gene silencing was not fully penetrant [83]. The establishment of a highly specific technique for the direct knockout of the target gene has been fundamental to overcome these limitations. This has now become feasible with the arrival of CRISPR technology [84]. After the first successful gene editing in mammalian cells in 2013 with CRISPR [85], this technology has found broad application in fields ranging from the food industry to human health [86].

The chromosomes of prokaryotic species can contain from one to eight CRISPR loci consisting of: (i) direct repeats bordered with spacers; (ii) leader sequence adjacent to the CRISPR array; and (iii) CRISPR-associated (cas) genes coding for Cas proteins (93 different cas genes have been identified until now) [86]. In brief, the system consists of an RNA-guided nuclease that introduces insertions or deletions in target genomic sites [86]. The most widely used version of this approach involves mutagenesis catalysed by a complex of the Streptococcus pyogenes Cas9 and a small guide RNA [87]. Nonetheless, commercially available variants of this system involve using a deactivated form of Cas9 to tether activator (CRISPRa) or repressor protein domains (CRISPRi) to the target sequence for the purpose of enhancing or supressing target gene expression, respectively [87].

To date, the CRISPR/Cas9 system has been successfully applied in free-living nematodes, parasitic nematodes and trematodes through microinjection, electroporation or lentiviral-mediated transduction [83]. However, to our knowledge, CRISPR-based genome editing studies have not yet been reported for cestodes, likely because of the requirement for the identification and isolation of germinal cells as well as the development of a procedure for the stable transfection [34].

Many targeted mutagenesis successes have been reported for S. stercoralis, providing more details about the biology of this organism and opening the possibility of applying this technique in related genera of parasites [29]. Mutations in S. stercoralis as well as in S. ratti have been created by transducing with basic CRISPR elements and selectable markers encoded in plasmid vectors or by microinjecting gonads of free-living females with pre-formed nucleoproteins of a recombinant Cas9 and in vitro transcribed genomic RNAs [88]. In S. stercoralis and S. ratti, the disruption of the twitchin protein (Ss-ucn-22 gene), a large intracellular muscle protein homologous to mammalian connectin, generated free-living adults and infective larvae with severe motility defects (Fig. 1; Table 1) [88, 89]. Notwithstanding, the first-generation larvae were heterozygous for the CRISPR/Cas9-mediated insertion. Consequently, the next paramount goal was to adapt the CRISPR/Cas9 system in Strongyloides spp. for rendering the mutations homozygous [29]. Considering the hermaphroditism of C. elegans, homozygous lines for the mutation were derived easily within a single second generation for subsequent rearing, genotyping and phenotypic analysis [29]. The relatively low efficiency of S. stercoralis infection in the gerbil, as well as the lack of homozygous first-generation larvae, for both S. stercoralis and S. ratti initially hampered attempts to obtain stable transgenic lines [29]. In 2017, Gang et al. overcame this limitation, obtaining homozygous deletions of the twitchin gene unc-22 in approximately 2–5% of the F1 infective L3s in both S. stercoralis and S. ratti microinjected with plasmid vectors or ribonucleoprotein particle (RNP) complexes into the syncytial gonads [88]. Comparatively, transduction of parental worms with plasmid-encoded CRISPR/Cas9 elements has produced more efficient mutagenesis than transduction with pre-formed nucleoproteins. As in C. elegans, the deletion of twitchin, which encodes a large intracellular muscle protein homologous to mammalian connectin, causes an uncoordinated phenotype being more frequent in S. stercoralis than in S. ratti. The authors also suggested the improvement of the strategy by targeting both free-living males and females to improve the incidence of F1 homozygous knockouts [86]. Subsequent CRISPR/Cas9-mediated homozygous disruption methods have helped link some S. stercoralis-specific genes to functions involved in host infection (disruption of Ss-tax-4 severely affects positive thermotaxis toward host body temperatures) [88] and, recently, to development (disruption of DAF-12 and DIP-1 proteins are crucial for the developmental arrest and reactivation of infectious L3, respectively) [91, 92].

The potential off-target sites, the high variability in temporal patterns of expression and the difficult selection of appropriate tissue-specific promoters and other regulatory elements have created the need for alternative CRISPR/Cas9 approaches. The need to express Cas9/single guide RNA (sgRNA) from transgenes has been obviated in the free-living nematodes C. elegans and P. pacificus by using pre-formed nucleoproteins in 2013 and 2015, respectively [19, 93]. Cas9 has been commercialised in a lyophilised form, and is ready to be combined with synthetic sgRNAs to be introduced, for example, into the syncytial gonads of the worms by microinjection. The transient activity renders mutant progeny produced within 9 h of microinjection in P. pacificus [19, 94]. In addition, heterozygous mutations in both helminths could be rendered homozygous by self-fertilisation and crossing of worms cultured through multiple generations [29]. Recently, Adams and co-workers combined liposome-based technology with microinjection to produce the CRISPR-mediated mutagenesis in the nematodes Auanema rhodensis (free-living) and S. stercoralis (parasitic) [95]. The authors accomplished the mutagenesis of A. rhodensis for the first time, obtaining a right-handed roller phenotype even in the F2 generation following dsRNA administration. However, the impaired progressive motility of roller mutants of S. stercoralis hindered host passage of mutant larvae to ascertain their infectivity and heritability [95]. CRISPR-mediated transfection in nematodes also has been carried out in B. malayi, successfully integrating the luciferase reporter in the genome of this species with no off-target insertions found and, thus, opening the possibility to precisely edit the genome of this important filarial parasite [89, 96].

In addition, the study of genetic mutations or transcriptional alterations that disable essential functions for invasion, migration and infection establishment was impractical before researchers started to apply conditional expression [29]. Although temporal as well as anatomical expression patterns depend upon the specific promoter, the possibility to control or regulate the expression of the gene of interest would help, especially in helminth biology research, since it could open the possibility to study pre-parasitic larvae and the biology and host interactions of post-infective larvae and parasitic worms.

Many alternatives for the conditioning of transgene expression have been applied. Regulation at the transcriptional level was attained by using promoters with tetracycline-regulated motifs, while for post-translational regulation researchers used recombinant proteins fused to degradation domains which can be stabilised in the presence of specific analogues. This latter system has proven effective in the malaria parasite Plasmodium falciparum through the design of a recombinant protein fused to the degradation domain of E. coli dihydrofolate reductase (DHFR-DD). This domain is stabilised in the presence of the folate analogue antibiotic trimethoprim (TMP), avoiding proteasome degradation. In addition, this system has also been successfully applied to S. stercoralis larvae for the regulatable expression of GFP in the presence of TMP [29]. Additionally, the Cas9 nuclease can be expressed in two fragments tethering the FK506-binding protein 12 (FKBP) and the FKBP-rapamycin binding (FRB) domains, respectively. These fragments combine to reconstitute the active nuclease in the presence of the drug and, thus, target specific genomic sites by appropriate sgRNAs. Another advantage of this system is the lower indel frequencies in validated on- and off-target sites when compared to wild-type Cas9. Lastly, a split inactive Cas9 was also used for transcriptional activation by the fusion of the FKBP fragment to the VP64 transcriptional activator [97].

In trematodes, at the end of the 2010s, CRISPR/Cas9 was used to mediate the knockout of the granulin gene in Opisthorchis viverrini through electroporation (Fig. 1; Table 1) [20, 89]. This liver fluke represents the principal risk factor for cholangiocarcinoma (CCA) in countries such as Thailand [98, 99]. The mutation resulted in reduced pathology when gene-edited parasites colonised the biliary tract of hamsters [20]. In a recent preprint, these same investigators appeared to confirm a role for liver fluke granulin in malignant transformation of the biliary tract [100]. Following upon the findings with VSVG pseudotyped MLV, VSVG pseudotyped HIV-1 (human immunodeficiency virus 1) lentiviral virions was also reported to facilitate CRISPR-based transfection of schistosomes [80, 89] and to deliver proviral transgenes into the chromosomes of S. mansoni [101]. For example, in 2019, Ittiprasert and co-workers tested this technique to edit the omega-1 gene of S. mansoni via electroporation or by transduction with lentiviral particles (Fig. 1; Table 1) [102]. Similar efficiency rates for both techniques were reported. Notably, phenotypes resulting from disruption of S. mansoni omega 1 demonstrate the crucial roles of this ribonuclease in the polarisation of Th2 cytokine responses and in the formation of pulmonary granulomas surrounding the eggs of this schistosome. These host responses were significantly reduced in the presence of mutated eggs [102]. Recently, Ittiprasert and co-workers also demonstrated that a second programmable nuclease, Cas12a, also was active in S. mansoni; in a side-by-side comparison targeting the omega-1 gene, Cas12a exhibited significantly higher efficiency than Cas9 for programmed knockout of this egg-stage expressed enzyme [103].

Soon after the appearance of the initial report by Ittiprasert and colleagues confirming the activity of Cas9 in schistosomes [99], Rinaldi and co-authors induced CRISPR/Cas9-mediated deletion mutations in the SULT-OR gene that encodes a sulfotransferase expressed in the parasitic stages of S. mansoni; this gene is required for anthelmintic activity of oxamniquine against S. mansoni [104]. Divergent mutagenic efficiencies were observed between different developmental stages, with adults shown to be the most susceptible stage to programmed deletions in the SULT-OR gene, yet knockdown at the mRNA level was not observed [104]. Therefore, researchers keep working on further optimisation of CRISPR-Cas protocols for the generation of a homozygous knockout in the SULT-OR gene [104]. Parallel experiments conducted by You et al. showed that the CRISPR/Cas9 technology also enables the knockin into the genome of the eggs of S. mansoni via electroporation [22]. These authors edited the AChE gene, introducing stop codons in exons 5 and 7 (Table 1), which revealed the potential immunomodulatory function of the domain located between these exons, since edited eggs elicited an increased Th2 response characterised by elevated levels of interleukin (IL)-4, IL-5, IL-10 and IL-13 [22]. Finally, Hulme et al. employed both RNAi and programmed gene editing approaches in parallel to demonstrate that the glycosyl hydrolase Smansoni α-N-acetylgalactosaminidase (SmNAGAL) plays a central role in the cellular machinery of glycan processing and modification, with dysregulation of coordinated parasite movement and egg production following both gene silencing or gene knockout of SmNAGAL [105].

Helminth transgenesis: current gaps and future perspectives

Advances in general genome manipulation have reached, to some degree, research initiatives on parasitic helminths, opening new possibilities for understanding the basic biology of these organisms and, thus, uncovering more potential therapeutic targets. However, genome manipulation in parasitic helminths still lags behind the current state-of-the-art capabilities for many other organisms. This is, in part, due to the specific complexities of parasitic helminths and their sophisticated life-cycles and the associated biochemical changes they deploy as they move between the free-living and parasitic environments.

Current methodologies have allowed the generation of transient expression, although these do involve an intensive workload and high cost and have variable success depending on the delivery method. Transient expression has resulted in the publications of a number of studies based on gene tagging and functional disruption. However, extended genomic research requires the establishment of stable transgenic lines to determine targets crucial for life-cycle development, host infection and parasite survival. All things considered, plasmid-based vectors helped to generate the first stable transgenic lines in some nematodes and trematodes [21, 31, 40, 47, 48], and CRISPR has also shown potential for the generation of transgenic lines in nematodes [88, 96] (Additional file 1: Table S1); however, reliable methods of delivering transgenes to the germlines of helminths need to be developed and established for most helminths.

Additionally, improvement of current transgenic tools, either through combining methodologies or refining current methods, will result in increased knowledge of helminth biology. For example, replacement of the genomic regulatory elements in transformation constructs has increased transgenesis efficiency. Indeed, substitution of the HCMV promoter by the hlh11 promoter of C. elegans and the addition of the tbb2 3’UTR in the vector used for the transgenesis of N. brasiliensis infective larvae produced a combined tenfold increase in its silencing capacity [82]. Additionally, the efficiency of a delivery approach may differ for each of the parasite life-stage and genes. Thus, several methods, alone or combined, must be tested. As an example, L1–L3 of H. contortus differ in their susceptibility to silencing depending on the method used: soaking-based silencing of the β-tubulin gene only renders phenotypic changes in the L3 but is ineffective for other genes in the same stage; the feeding method is not effective; and electroporation is effective in reducing transcript levels in L1 but larval death was observed [106,107,108].

Ideally, specific changes with stronger and sustained phenotypic effects will facilitate conclusive findings in helminth biology. However, limitations, such as off-target effects, can affect these phenotypic changes, and attention should be paid when applying any silencing and transgenesis technique. After all, the possibility to activate the cellular homology directed repair (HDR) processing providing a donor template with homologous ends, in conjunction with the variable collection of Cas9 formats, established CRISPR as the most specific, stable and flexible technique for genome editing. Despite CRISPR-based knockout experiments in helminths being initially limited to genes that are non-essential for worm survival, conditional transgene expression or regulable Cas9 activation has recently opened the possibility to interfere/disrupt these genes at the appropriate time. Nonetheless, for experiments based on a progressive loss-of-function, RNAi has demonstrated great potential since the resulting silencing level usually is dose-dependent, as shown in the silencing of the gynecophoral canal protein of S. japonicum [61]. Thus, although RNAi cannot completely knockout target genes, it can be useful to probe the functions of genes that are essential for parasite survival.

Conclusions

Much time has passed since the first genome sequencing technique appeared and substantial amounts of data on the biology of other organisms have accumulated, but research on helminths still faces important limitations, and extensive “omics” analyses are needed to deeply understand the nature of parasitism. Here, we have summarised the available techniques in genome editing for biological research on helminths. Different genome constructs as well as different carriers have been tested for transgenesis in helminths with variable or inconsistent results.

The most promising results have been attained through the conditional expression of the transgene since it allows for the study of pre- and post-infective stages. However, not only the initiation but also the regulation and the end of the expression need to be controlled to achieve a feasible system for the study of molecular biology in helminths. Consequently, genomic sites for DNA integration that do not go through chromatin silencing need to be identified at least in the developmental stages of the helminth under study and, ideally, the whole life-cycle. Thus, the activation, regulation and silencing of transgenes would be possible in any stage of the helminth, providing a flexible system for research.

Notwithstanding, this is far from the current research capacity since transgenesis is still facing methodological limitations, with robust culture and delivery methods remaining among the principal limitations. Even the recent and promising advanced technique, CRISPR/Cas, requires improved CRISPR systems delivery and transgenesis efficiency as well as measures to minimise undesired off-target events to successfully and securely edit genomes. With the current platforms in place, ambitious projects in helminth research will benefit from this technological progress. Establishing collaborations, the development, modification and delivery of technical advances and continued improvements in the quality of curated genomes applicable to the targeted helminth species can be expected to be repaid with notable step changes in this field. In turn, it is hoped that these advances will enable improved prognosis, diagnosis and treatments for the helminthiases of global public health and economical significance.

Availability of data and materials

Not applicable.

Abbreviations

AChE:

Acetylcholinesterases

Cas:

CRISPR-associated

CCA:

Cholangiocarcinoma

CMV:

Cytomegalovirus

CRISPR:

Clustered regularly interspaced palindromic repeats

DALYs:

Disability-adjusted life years

DHRF-DD:

Degradation domain of the dihydrofolate reductase

dsRNAs:

Double-stranded RNAs

FKBP:

FK506-binding protein

GFP:

Green fluorescent protein

HIV-1:

Human immunodeficiency virus 1

HDR:

Homology directed repair

miRNAs:

MicroRNAs

MLV:

Murine leukaemia retrovirus

ncRNAs:

Non-coding RNAs

PB:

Piggyback

RNAi:

RNA interference

STHs:

Soil-transmitted helminths

sgRNA:

Single guide RNA

shRNAs:

Short hairpin RNAs

shRNAmirs:

MiRNA-adapted short hairpin RNAs

SID:

Systemic RNA interference defective

siRNAs:

Small interfering RNAs

TMP:

Trimethoprim

VSVG:

Vesicular stomatitis virus glycoprotein

WGS:

Whole-genome shotgun

References

  1. World Health Organization. Ending the neglect to attain the Sustainable Development Goals: a road map for neglected tropical diseases 2021–2030. 2020. Geneva: World Health Organization. https://www.who.int/publications/i/item/9789240010352. Accessed 01 Oct 2021.

  2. Perera DJ, Ndao M. Promising technologies in the field of helminth vaccines. Front Immunol. 2021;12:711650.

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Donohue RE, Cross ZK, Michael E. The extent, nature, and pathogenic consequences of helminth polyparasitism in humans: a meta-analysis. PLoS Negl Trop Dis. 2019;13:e0007455.

    PubMed  PubMed Central  Google Scholar 

  4. Al Amin ASM, Wadhwa R. Helminthiasis. Treasure Island: StatPearls; 2021. https://www.ncbi.nlm.nih.gov/books/NBK560525/. Accessed 01 Oct 2021.

  5. Charlier J, Rinaldi L, Musella V, Ploeger HW, Chartier C, Vineer HR, et al. Initial assessment of the economic burden of major parasitic helminth infections to the ruminant livestock industry in Europe. Prev Vet Med. 2020;182:105103.

    CAS  PubMed  Google Scholar 

  6. Ghodeif AO, Jain H. Hookworm. Treasure Island: StatPearls; 2021. https://pubmed.ncbi.nlm.nih.gov/31536254/. Accessed 01 Oct 2021.

  7. Zawawi A, Else KJ. Soil-transmitted helminth vaccines: are we getting closer? Front Immunol. 2020;11:576748.

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Riveau G, Schacht A-M, Dompnier J-P, Deplanque D, Seck M, Waucquier N, et al. Safety and efficacy of the rSh28GST urinary schistosomiasis vaccine: a phase 3 randomized, controlled trial in Senegalese children. PLoS Negl Trop Dis. 2018;12:e0006968.

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Chapman PR, Webster R, Giacomin P, Llewellyn S, Becker L, Pearson MS, et al. Vaccination of human participants with attenuated Necator americanus hookworm larvae and human challenge in Australia: a dose-finding study and randomised, placebo-controlled, phase 1 trial. Lancet Infect Dis. 2021;21:1725–36.

    CAS  PubMed  Google Scholar 

  10. Diemert DJ, Bottazzi ME, Plieskatt J, Hotez PJ, Bethony JM. Lessons along the critical path: developing vaccines against human helminths. Trends Parasitol. 2018;34:747–58.

    PubMed  Google Scholar 

  11. Sotillo J, Pearson MS, Loukas A. Trematode genomics and proteomics. In: Toledo R, Fried B, editors. Digenetic trematodes. Cham: Springer International Publishing; 2019. p. 411–36.

    Google Scholar 

  12. International Helminth Genomes Consortium. Comparative genomics of the major parasitic worms. Nat Genet. 2019;51:163–74.

    CAS  Google Scholar 

  13. Ghedin E, Wang S, Spiro D, Caler E, Zhao Q, Crabtree J, et al. Draft genome of the filarial nematode parasite Brugia malayi. Science. 2007;317:1756–60.

    CAS  PubMed  PubMed Central  Google Scholar 

  14. WormBase ParaSite. Genome list. https://parasite.wormbase.org/species.html. Accessed 1 Oct 2021.

  15. Yoo WG, Kim D-W, Ju J-W, Cho PY, Kim TI, Cho S-H, et al. Developmental transcriptomic features of the carcinogenic liver fluke, Clonorchis sinensis. PLoS Negl Trop Dis. 2011;5:e1208.

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Davis RE, Parra A, LoVerde PT, Ribeiro E, Glorioso G, Hodgson S. Transient expression of DNA and RNA in parasitic helminths by using particle bombardment. Proc Natl Acad Sci USA. 1999;96:8687–92.

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Higazi TB, Merriweather A, Shu L, Davis R, Unnasch TR. Brugia malayi: transient transfection by microinjection and particle bombardment. Exp Parasitol. 2002;100:95–102.

    CAS  PubMed  Google Scholar 

  18. Lok JB, Massey HC. Transgene expression in Strongyloides stercoralis following gonadal microinjection of DNA constructs. Mol Biochem Parasitol. 2002;119:279–84.

    CAS  PubMed  Google Scholar 

  19. Witte H, Moreno E, Rödelsperger C, Kim J, Kim J-S, Streit A, et al. Gene inactivation using the CRISPR/Cas9 system in the nematode Pristionchus pacificus. Dev Genes Evol. 2015;225:55–62.

    CAS  PubMed  Google Scholar 

  20. Arunsan P, Ittiprasert W, Smout MJ, Cochran CJ, Mann VH, Chaiyadet S, et al. Programmed knockout mutation of liver fluke granulin attenuates virulence of infection-induced hepatobiliary morbidity. Elife. 2019;8:e41463.

    PubMed  PubMed Central  Google Scholar 

  21. Douglas B, Wei Y, Li X, Ferguson A, Hung L-Y, Pastore C, et al. Transgenic expression of a T cell epitope in Strongyloides ratti reveals that helminth-specific CD4+ T cells constitute both Th2 and Treg populations. PLoS Pathog. 2021;17:e1009709.

    CAS  PubMed  PubMed Central  Google Scholar 

  22. You H, Mayer JU, Johnston RL, Sivakumaran H, Ranasinghe S, Rivera V, et al. CRISPR/Cas9-mediated genome editing of Schistosoma mansoni acetylcholinesterase. FASEB J. 2021;35.

  23. Correnti JM, Brindley PJ, Pearce EJ. Long-term suppression of cathepsin B levels by RNA interference retards schistosome growth. Mol Biochem Parasitol. 2005;143:209–15.

    CAS  PubMed  Google Scholar 

  24. Tran MH, Freitas TC, Cooper L, Gaze S, Gatton ML, Jones MK, et al. Suppression of mRNAs encoding tegument tetraspanins from Schistosoma mansoni results in impaired tegument turnover. PLoS Pathog. 2010;6:e1000840.

    PubMed  PubMed Central  Google Scholar 

  25. Palevich N, Britton C, Kamenetzky L, Mitreva M, de Moraes MM, Bennuru S, et al. Tackling hypotheticals in helminth genomes. Trends Parasitol. 2018;34:179–83.

    PubMed  Google Scholar 

  26. Carroll D. Genome editing: past, present, and future. Yale J Biol Med. 2017;90:653–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Zamanian M, Andersen EC. Prospects and challenges of CRISPR/Cas genome editing for the study and control of neglected vector-borne nematode diseases. FEBS J. 2016;283:3204–21.

    CAS  PubMed  PubMed Central  Google Scholar 

  28. Kimble J, Hodgkin J, Smith T, Smith J. Suppression of an amber mutation by microinjection of suppressor tRNA in C. elegans. Nature. 1982;299:456–8.

    CAS  PubMed  Google Scholar 

  29. Lok JB, Shao H, Massey HC, Li X. Transgenesis in Strongyloides and related parasitic nematodes: historical perspectives, current functional genomic applications and progress towards gene disruption and editing. Parasitology. 2017;144:327–42.

    CAS  PubMed  Google Scholar 

  30. Mello CC, Kramer JM, Stinchcomb D, Ambros V. Efficient gene transfer in C. elegans: extrachromosomal maintenance and integration of transforming sequences. EMBO J. 1991;10:3959–70.

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Shao H, Li X, Nolan TJ, Massey HC, Pearce EJ, Lok JB. Transposon-mediated chromosomal integration of transgenes in the parasitic nematode Strongyloides ratti and establishment of stable transgenic lines. PLoS Pathog. 2012;8:e1002871.

    CAS  PubMed  PubMed Central  Google Scholar 

  32. Spiliotis M, Lechner S, Tappe D, Scheller C, Krohne G, Brehm K. Transient transfection of Echinococcus multilocularis primary cells and complete in vitro regeneration of metacestode vesicles. Int J Parasitol. 2008;38:1025–39.

    CAS  PubMed  Google Scholar 

  33. Dvorák J, Beckmann S, Lim K-C, Engel JC, Grevelding CG, McKerrow JH, et al. Biolistic transformation of Schistosoma mansoni: Studies with modified reporter-gene constructs containing regulatory regions of protease genes. Mol Biochem Parasitol. 2010;170:37–40.

    PubMed  Google Scholar 

  34. Moguel B, Moreno-Mendoza N, Bobes RJ, Carrero JC, Chimal-Monroy J, Díaz-Hernández ME, et al. Transient transgenesis of the tapeworm Taenia crassiceps. Springerplus. 2015;4:496.

    PubMed  PubMed Central  Google Scholar 

  35. Evans T. Transformation and microinjection. WormBook. 2006. https://doi.org/10.1895/wormbook.1.108.1.

    Article  Google Scholar 

  36. Grant WN, Skinner SJM, Newton-Howes J, Grant K, Shuttleworth G, Heath DD, et al. Heritable transgenesis of Parastrongyloides trichosuri: a nematode parasite of mammals. Int J Parasitol. 2006;36:475–83.

    CAS  PubMed  Google Scholar 

  37. Li X, Massey HC, Nolan TJ, Schad GA, Kraus K, Sundaram M, et al. Successful transgenesis of the parasitic nematode Strongyloides stercoralis requires endogenous non-coding control elements. Int J Parasitol. 2006;36:671–9.

    CAS  PubMed  Google Scholar 

  38. Junio AB, Li X, Massey HC, Nolan TJ, Todd Lamitina S, Sundaram MV, et al. Strongyloides stercoralis: cell- and tissue-specific transgene expression and co-transformation with vector constructs incorporating a common multifunctional 3’ UTR. Exp Parasitol. 2008;118:253–65.

    CAS  PubMed  Google Scholar 

  39. Li X, Shao H, Junio A, Nolan TJ, Massey HC, Pearce EJ, et al. Transgenesis in the parasitic nematode Strongyloides ratti. Mol Biochem Parasitol. 2011;179:114–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  40. Lok J. piggyBac: a vehicle for integrative DNA transformation of parasitic nematodes. Mob Genet Elements. 2013;3:e24417.

    PubMed  PubMed Central  Google Scholar 

  41. Morales ME, Mann VH, Kines KJ, Gobert GN, Fraser MJ, Kalinna BH, et al. piggyBac transposon mediated transgenesis of the human blood fluke, Schistosoma mansoni. FASEB J. 2007;21:3479–89.

    CAS  PubMed  Google Scholar 

  42. Brindley PJ, Laha T, McManus DP, Loukas A. Mobile genetic elements colonizing the genomes of metazoan parasites. Trends Parasitol. 2003;19:79–87.

    CAS  PubMed  Google Scholar 

  43. Boulin T, Bessereau J-L. Mos1-mediated insertional mutagenesis in Caenorhabditis elegans. Nat Protoc. 2007;2:1276–87.

    CAS  PubMed  Google Scholar 

  44. Kines KJ, Mann VH, Morales ME, Shelby BD, Kalinna BH, Gobert GN, et al. Transduction of Schistosoma mansoni by vesicular stomatitis virus glycoprotein-pseudotyped Moloney murine leukemia retrovirus. Exp Parasitol. 2006;112:209–20.

    CAS  PubMed  Google Scholar 

  45. Kines KJ, Rinaldi G, Okatcha TI, Morales ME, Mann VH, Tort JF, et al. Electroporation facilitates introduction of reporter transgenes and virions into Schistosome eggs. PLoS Negl Trop Dis. 2010;4:e593.

    PubMed  PubMed Central  Google Scholar 

  46. Kines KJ, Morales ME, Mann VH, Gobert GN, Brindley PJ. Integration of reporter transgenes into Schistosoma mansoni chromosomes mediated by pseudotyped murine leukemia virus. FASEB J. 2008;22:2936–48.

    CAS  PubMed  PubMed Central  Google Scholar 

  47. Rinaldi G, Eckert SE, Tsai IJ, Suttiprapa S, Kines KJ, Tort JF, et al. Germline transgenesis and insertional mutagenesis in Schistosoma mansoni mediated by murine leukemia virus. PLoS Pathog. 2012;8:e1002820.

    CAS  PubMed  PubMed Central  Google Scholar 

  48. Mann VH, Suttiprapa S, Skinner DE, Brindley PJ, Rinaldi G. Pseudotyped murine leukemia virus for schistosome transgenesis: approaches, methods and perspectives. Transgenic Res. 2014;23:539–56.

    CAS  PubMed  Google Scholar 

  49. Liang S, Knight M, Jolly ER. Polyethyleneimine mediated DNA transfection in Schistosome parasites and regulation of the WNT signaling pathway by a dominant-negative SmMef2. PLoS Negl Trop Dis. 2013;7:e2332.

    CAS  PubMed  PubMed Central  Google Scholar 

  50. Xu S, Liu C, Tzertzinis G, Ghedin E, Evans CC, Kaplan R, et al. In vivo transfection of developmentally competent Brugia malayi infective larvae. Int J Parasitol. 2011;41:355–62.

    PubMed  Google Scholar 

  51. Nozawa M, Kinjo S. Noncoding RNAs, origin and evolution of. In: Nozawa m, editor. Encyclopedia of evolutionary biology. Amsterdam: Elsevier; 2016. p. 130–5.

  52. Feinberg EH, Hunter CP. Transport of dsRNA into cells by the transmembrane protein SID-1. Science. 2003;301:1545–7.

    CAS  PubMed  Google Scholar 

  53. Krautz-Peterson G, Bhardwaj R, Faghiri Z, Tararam CA, Skelly PJ. RNA interference in schistosomes: machinery and methodology. Parasitology. 2010;137:485–95.

    CAS  PubMed  Google Scholar 

  54. Dalzell JJ, Warnock ND, Mcveigh P, Marks NJ, Mousley A, Atkinson L, et al. Considering RNAi experimental design in parasitic helminths. Parasitology. 2012;139:589–604.

    CAS  PubMed  Google Scholar 

  55. Moguel B, Bobes RJ, Carrero JC, Laclette JP. Transfection of platyhelminthes. Biomed Res Int. 2015;2015:1–9.

    Google Scholar 

  56. Delpu Y, Larrieu D, Gayral M, Arvanitis D, Dufresne M, Cordelier P, et al. Noncoding RNAs. In: Egger G, Arimondo P, editors. Drug discovery in cancer epigenetics. Amsterdam: Elsevier; 2016. p. 305–26.

  57. Hussein AS, Kichenin K, Selkirk ME. Suppression of secreted acetylcholinesterase expression in Nippostrongylus brasiliensis by RNA interference. Mol Biochem Parasitol. 2002;122:91–4.

    CAS  PubMed  Google Scholar 

  58. Aboobaker AA, Blaxter ML. Use of RNA interference to investigate gene function in the human filarial nematode parasite Brugia malayi. Mol Biochem Parasitol. 2003;129:41–51.

    CAS  PubMed  Google Scholar 

  59. Samarasinghe B, Knox DP, Britton C. Factors affecting susceptibility to RNA interference in Haemonchus contortus and in vivo silencing of an H11 aminopeptidase gene. Int J Parasitol. 2011;41:51–9.

    CAS  PubMed  Google Scholar 

  60. Chen N, Xu M-J, Nisbet AJ, Huang C-Q, Lin R-Q, Yuan Z-G, et al. Ascaris suum: RNAi mediated silencing of enolase gene expression in infective larvae. Exp Parasitol. 2011;127:142–6.

    CAS  PubMed  Google Scholar 

  61. Cheng G-F, Lin J-J, Shi Y, Jin Y-X, Fu Z-Q, Jin Y-M, et al. Dose-dependent inhibition of gynecophoral canal protein gene expression in vitro in the Schistosome (Schistosoma japonicum) by RNA interference. Acta Biochim Byophys Sin. 2005;37:386–90.

    CAS  Google Scholar 

  62. McGonigle L, Mousley A, Marks NJ, Brennan GP, Dalton JP, Spithill TW, et al. The silencing of cysteine proteases in Fasciola hepatica newly excysted juveniles using RNA interference reduces gut penetration. Int J Parasitol. 2008;38:149–55.

    CAS  PubMed  Google Scholar 

  63. Dell’Oca N, Basika T, Corvo I, Castillo E, Brindley PJ, Rinaldi G, et al. RNA interference in Fasciola hepatica newly excysted juveniles: long dsRNA induces more persistent silencing than siRNA. Mol Biochem Parasitol. 2014;197:28–35.

    PubMed  Google Scholar 

  64. Wang J, Paz C, Padalino G, Coghlan A, Lu Z, Gradinaru I, et al. Large-scale RNAi screening uncovers therapeutic targets in the parasite Schistosoma mansoni. Science. 2020;369:1649–53.

    CAS  PubMed  PubMed Central  Google Scholar 

  65. Bibo-Verdugo B, Wang SC, Almaliti J, Ta AP, Jiang Z, Wong DA, et al. The proteasome as a drug target in the metazoan pathogen, Schistosoma mansoni. ACS Infect Dis. 2019;5:1802–12.

    CAS  PubMed  PubMed Central  Google Scholar 

  66. Pierson L, Mousley A, Devine L, Marks NJ, Day TA, Maule AG. RNA interference in a cestode reveals specific silencing of selected highly expressed gene transcripts. Int J Parasitol. 2010;40:605–15.

    CAS  PubMed  Google Scholar 

  67. Sripa J, Pinlaor P, Brindley PJ, Sripa B, Kaewkes S, Robinson MW, et al. RNA interference targeting cathepsin B of the carcinogenic liver fluke Opisthorchis viverrini. Parasitol Int. 2011;60:283–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  68. Piratae S, Tesana S, Jones MK, Brindley PJ, Loukas A, Lovas E, et al. Molecular characterization of a tetraspanin from the human liver fluke, Opisthorchis viverrini. PLoS Negl Trop Dis. 2012;6:e1939.

    CAS  PubMed  PubMed Central  Google Scholar 

  69. Mizukami C, Spiliotis M, Gottstein B, Yagi K, Katakura K, Oku Y. Gene silencing in Echinococcus multilocularis protoscoleces using RNA interference. Parasitol Int. 2010;59:647–52.

    CAS  PubMed  Google Scholar 

  70. Pouchkina-Stantcheva NN, Cunningham LJ, Hrčkova G, Olson PD. RNA-mediated gene suppression and in vitro culture in Hymenolepis microstoma. Int J Parasitol. 2013;43:641–6.

    CAS  PubMed  Google Scholar 

  71. Correnti JM, Pearce EJ. Transgene expression in Schistosoma mansoni: introduction of RNA into schistosomula by electroporation. Mol Biochem Parasitol. 2004;137:75–9.

    CAS  PubMed  Google Scholar 

  72. Selkirk ME, Huang SC, Knox DP, Britton C. The development of RNA interference (RNAi) in gastrointestinal nematodes. Parasitology. 2012;139:605–12.

    CAS  PubMed  Google Scholar 

  73. Huang SC-C, Chan DTY, Smyth DJ, Ball G, Gounaris K, Selkirk ME. Activation of Nippostrongylus brasiliensis infective larvae is regulated by a pathway distinct from the hookworm Ancylostoma caninum. Int J Parasitol. 2010;40:1619–28.

    CAS  PubMed  Google Scholar 

  74. Urwin PE, Lilley CJ, Atkinson HJ. Ingestion of double-stranded RNA by Preparasitic juvenile Cyst nematodes leads to RNA interference. Mol Plant Microbe Interact. 2002;15:747–52.

    CAS  PubMed  Google Scholar 

  75. Rosso M-N, Dubrana MP, Cimbolini N, Jaubert S, Abad P. Application of RNA interference to root-knot nematode genes encoding esophageal gland proteins. Mol Plant Microbe Interact. 2005;18:615–20.

    CAS  PubMed  Google Scholar 

  76. Adell T, Cebria F, Salo E. Gradients in planarian regeneration and homeostasis. Cold Spring Harb Perspect Biol. 2010;2:a000505.

    PubMed  PubMed Central  Google Scholar 

  77. Li J, Xiang M, Zhang R, Xu B, Hu W. RNA interference in vivo in Schistosoma japonicum: establishing and optimization of RNAi mediated suppression of gene expression by long dsRNA in the intra-mammalian life stages of worms. Biochem Biophys Res Commun. 2018;503:1004–10.

    CAS  PubMed  Google Scholar 

  78. Cinkornpumin JK, Hong RL. RNAi mediated gene knockdown and transgenesis by microinjection in the necromenic nematode Pristionchus pacificus. J Vis Exp. 2011;56:e3270.

  79. Kalinna BH, Brindley PJ. Manipulating the manipulators: advances in parasitic helminth transgenesis and RNAi. Trends Parasitol. 2007;23:197–204.

    CAS  PubMed  Google Scholar 

  80. Hagen J, Young ND, Every AL, Pagel CN, Schnoeller C, Scheerlinck J-PY, et al. Omega-1 knockdown in Schistosoma mansoni eggs by lentivirus transduction reduces granuloma size in vivo. Nat Commun. 2014;5:5375.

    PubMed  Google Scholar 

  81. Taxman DJ, Moore CB, Guthrie EH, Huang MT-H. Short hairpin RNA (shRNA): design, delivery, and assessment of gene knockdown. In: Sioud M, editor. RNA therapeutics. Totowa: Humana Press; 2010. p. 139–56.

    Google Scholar 

  82. Hagen J, Sarkies P, Selkirk ME. Lentiviral transduction facilitates RNA interference in the nematode parasite Nippostrongylus brasiliensis. PLoS Pathog. 2021;17:e1009286.

    CAS  PubMed  PubMed Central  Google Scholar 

  83. Du X, McManus DP, French JD, Jones MK, You H. CRISPR/Cas9: a new tool for the study and control of helminth parasites. BioEssays. 2021;43:2000185.

    Google Scholar 

  84. Doudna JA, Charpentier E. The new frontier of genome engineering with CRISPR-Cas9. Science. 2014;346:1258096.

    PubMed  Google Scholar 

  85. Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, et al. Multiplex genome engineering using CRISPR/Cas systems. Science. 2013;339:819–23.

    CAS  PubMed  PubMed Central  Google Scholar 

  86. Nidhi S, Anand U, Oleksak P, Tripathi P, Lal JA, Thomas G, et al. Novel CRISPR–Cas systems: an updated review of the current achievements, applications, and future research perspectives. Int J Mol Sci. 2021;22:3327.

    CAS  PubMed  PubMed Central  Google Scholar 

  87. Mitsunobu H, Teramoto J, Nishida K, Kondo A. Beyond native Cas9: manipulating genomic information and function. Trends Biotechnol. 2017;35:983–96.

    CAS  PubMed  Google Scholar 

  88. Gang SS, Castelletto ML, Bryant AS, Yang E, Mancuso N, Lopez JB, et al. Targeted mutagenesis in a human-parasitic nematode. PLoS Pathog. 2017;13:e1006675.

    PubMed  PubMed Central  Google Scholar 

  89. Sankaranarayanan G, Berriman M, Rinaldi G. An uneven race: genome editing for parasitic worms. Nat Rev Microbiol. 2021;19:621–621.

    CAS  PubMed  Google Scholar 

  90. Bryant AS, Hallem EA. Temperature-dependent behaviors of parasitic helminths. Neurosci Lett. 2018;687:290–303.

    CAS  PubMed  PubMed Central  Google Scholar 

  91. Cheong MC, Wang Z, Jaleta TG, Li X, Lok JB, Kliewer SA, et al. Identification of a nuclear receptor/coactivator developmental signaling pathway in the nematode parasite Strongyloides stercoralis. Proc Natl Acad Sci USA. 2021;118:e2021864118.

    CAS  PubMed  PubMed Central  Google Scholar 

  92. Wang Z, Cheong MC, Tsien J, Deng H, Qin T, Stoltzfus JD, et al. Characterization of the endogenous DAF-12 ligand and its use as an anthelmintic agent in Strongyloides stercoralis. Elife. 2021;10:e73535.

    PubMed  PubMed Central  Google Scholar 

  93. Cho SW, Lee J, Carroll D, Kim J-S, Lee J. Heritable gene knockout in Caenorhabditis elegans by direct injection of Cas9–sgRNA ribonucleoproteins. Genetics. 2013;195:1177–80.

    CAS  PubMed  PubMed Central  Google Scholar 

  94. Nakayama K, Ishita Y, Chihara T, Okumura M. Screening for CRISPR/Cas9-induced mutations using a co-injection marker in the nematode Pristionchus pacificus. Dev Genes Evol. 2020;230:257–64.

    CAS  PubMed  Google Scholar 

  95. Adams S, Pathak P, Shao H, Lok JB, Pires-daSilva A. Liposome-based transfection enhances RNAi and CRISPR-mediated mutagenesis in non-model nematode systems. Sci Rep. 2019;9:483.

    PubMed  PubMed Central  Google Scholar 

  96. Liu C, Grote A, Ghedin E, Unnasch TR. CRISPR-mediated transfection of Brugia malayi. PLoS Negl Trop Dis. 2020;14:e0008627.

    CAS  PubMed  PubMed Central  Google Scholar 

  97. Zetsche B, Volz SE, Zhang F. A split-Cas9 architecture for inducible genome editing and transcription modulation. Nat Biotechnol. 2015;33:139–42.

    CAS  PubMed  Google Scholar 

  98. Sripa B, Brindley PJ, Mulvenna J, Laha T, Smout MJ, Mairiang E, et al. The tumorigenic liver fluke Opisthorchis viverrini—multiple pathways to cancer. Trends Parasitol. 2012;28:395–407.

    CAS  PubMed  PubMed Central  Google Scholar 

  99. Brindley PJ, Bachini M, Ilyas SI, Khan SA, Loukas A, Sirica AE, et al. Cholangiocarcinoma. Nat Rev Dis Primers. 2021;7:65.

    PubMed  Google Scholar 

  100. Chaiyadet S, Tangkawattana S, Smout MJ, Ittiprasert W, Mann VH, Deenonpoe R, et al. Programmed knockout mutation of liver fluke granulin, Ov-grn-1, impedes malignant transformation during chronic opisthorchiasis. bioRxiv. 2021;7:65.

    Google Scholar 

  101. Suttiprapa S, Rinaldi G, Tsai IJ, Mann VH, Dubrovsky L, Yan H, et al. HIV-1 integrates widely throughout the genome of the human blood fluke Schistosoma mansoni. PLoS Pathog. 2016;12:e1005931.

    PubMed  PubMed Central  Google Scholar 

  102. Ittiprasert W, Mann VH, Karinshak SE, Coghlan A, Rinaldi G, Sankaranarayanan G, et al. Programmed genome editing of the omega-1 ribonuclease of the blood fluke, Schistosoma mansoni. Elife. 2019;8:e41337.

    PubMed  PubMed Central  Google Scholar 

  103. Ittiprasert W, Chatupheeraphat C, Mann VH, Li W, Miller A, Ogunbayo T, et al. RNA-Guided AsCas12a- and SpCas9-catalyzed knockout and homology directed repair of the omega-1 locus of the human blood fluke, Schistosoma mansoni. Int J Med Sci. 2022;23:631.

    CAS  Google Scholar 

  104. Sankaranarayanan G, Coghlan A, Driguez P, Lotkowska ME, Sanders M, Holroyd N, et al. Large CRISPR-Cas-induced deletions in the oxamniquine resistance locus of the human parasite Schistosoma mansoni. Wellcome Open Res. 2021;5:178.

    PubMed  PubMed Central  Google Scholar 

  105. Hulme BJ, Geyer KK, Forde-Thomas JE, Padalino G, Phillips DW, Ittiprasert W, et al. Schistosoma mansoni α-N-acetylgalactosaminidase (SmNAGAL) regulates coordinated parasite movement and egg production. PLoS Pathog. 2022;18:e1009828.

    CAS  PubMed  PubMed Central  Google Scholar 

  106. Issa Z, Grant WN, Stasiuk S, Shoemaker CB. Development of methods for RNA interference in the sheep gastrointestinal parasite Trichostrongylus colubriformis. Int J Parasitol. 2005;35:935–40.

    CAS  PubMed  Google Scholar 

  107. Geldhof P, Murray L, Couthier A, Gilleard JS, McLauchlan G, Knox DP, et al. Testing the efficacy of RNA interference in Haemonchus contortus. Int J Parasitol. 2006;36:801–10.

    CAS  PubMed  Google Scholar 

  108. Kotze AC, Bagnall NH. RNA interference in Haemonchus contortus: suppression of beta-tubulin gene expression in L3, L4 and adult worms in vitro. Mol Biochem Parasitol. 2006;145:101–10.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We acknowledge support from the National Cancer Institute (NCI), US National Institutes of Health (NIH) award R01CA164719 AL, PJB) and the Wellcome Trust (WT), grant number 107475/Z/15/Z (PJB). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NCI, NIH, or WT.

Funding

MJQ and JS are recipients of a PFIS contract (FI20CIII/00013) and a Miguel Servet contract (CP17III/00002), respectively, by the Instituto de Salud Carlos III (ISCIII). This research was supported by grants MPY 406/18 and MPY 504/19 from the ISCIII.

Author information

Authors and Affiliations

Authors

Contributions

MQ and JS wrote the manuscript. MJP, PJB and AL reviewed the manuscript and provided comments. All authors read and approved the final manuscript.

Corresponding author

Correspondence to J. Sotillo.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Competing interests

The authors declare that this study was performed without any commercial or financial relationships construable as potential conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1: Table S1.

Extended details in the historical advances in the transgenesis of parasitic helminths.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Quinzo, M.J., Perteguer, M.J., Brindley, P.J. et al. Transgenesis in parasitic helminths: a brief history and prospects for the future. Parasites Vectors 15, 110 (2022). https://doi.org/10.1186/s13071-022-05211-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13071-022-05211-z

Keywords

  • Helminths
  • Genetic edition
  • Transgenesis
  • CRISPR
  • RNAi